Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.

Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P. · 2021

Read Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. by Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8611377.txt.

Introduction

Gobeil and co-authors study how natural mutations change the spike protein of SARS-CoV-2. Variants of concern can spread faster or dodge antibodies. The team looked at spike forms from mink-linked spread and from the alpha, beta, and gamma variants. They used structural and functional tests to see what each change does.

Mutations traded off between three effects. Some made the spike more stable. Others raised binding to the human ACE2 receptor. A third set helped the virus resist neutralizing antibodies. Together, the changes kept the spike able to infect cells while evading defense. The work helps explain why these variants spread and why vaccine defense can drop.

Catalog record

CREATORGobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE91 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8611377

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity By Sophie M-C Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Victoria Stalls, Megan F Kopp, Kartik Manne, Dapeng Li, Kevin Wiehe, Kevin O Saunders, Robert J Edwards Published in: Science (New York, N.y.) DOI: 10.1126/science.abi6226 ABSTRACT SARS-CoV-2 from alpha to epsilon As battles to contain the COVID-19 pandemic continue, attention is focused on emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that have been deemed variants of concern because they are resistant to antibodies elicited by infection or vaccination or they increase transmissibility or disease severity. Three papers used functional and structural studies to explore how mutations in the viral spike protein affect its ability to infect host cells and to evade host immunity. Gobeil et al. looked at a variant spike protein involved in transmission between minks and humans, as well as the B1.1.7 (alpha), B.1.351 (beta), and P1 (gamma) spike variants; Cai et al. focused on the alpha and beta variants; and McCallum et al. discuss the properties of the spike protein from the B1.1.427/B.1.429 (epsilon) variant. Together, these papers show a balance among mutations that enhance stability, those that increase binding to the human receptor ACE2, and those that confer resistance to neutralizing antibodies. —VV The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19, threatens to prolong an already devastating pandemic. Some variants have exhibited resistance in in vitro assays to neutralization by antibodies (Abs) and plasma from convalescent or vaccinated individuals, raising concerns that their resistance may reduce the efficiency of current vaccines (1, 2) (www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html). Additionally, SARS-CoV-2 transmission between humans and animals has been observed in mink farms, leading to culling of large mink populations in Denmark and other countries to prevent establishment of a nonhuman reservoir of SARS-CoV-2 variants (3). Changes in the spike (S) glycoprotein (4, 5) in these variants are under scrutiny because the S protein has a central role in engaging the angiotensin-converting enzyme 2 (ACE2) receptor to mediate cellular entry (6) and is a dominant target of neutralizing antibodies (nAbs) elicited by either vaccination or natural infection (7, 8). The prefusion SARS-CoV-2 S trimer is composed of S1 and S2 subunits separated by a furin cleavage site (Fig. 1). The S1 subunit contains the N-terminal domain (NTD), ACE2 receptor binding domain (RBD), and two subdomains (SD1 and SD2). The NTD and RBD are dominant targets for nAbs (9–12). The RBD transitions between a “closed” (“down”) receptor-inaccessible conformation and an “open” (“up”) conformation that allows binding to the ACE2 receptor (13–15). Variations in distal regions of the S protein can have allosteric effects on RBD up/down disposition (16–20), with SD1 and SD2 playing essential roles in modulating spike allostery (16). Whereas the S1 subunit shows large motions, the prefusion S2 remains mostly invariant. The S2 subunit contains a TMPRSS2 cleavage site (S2´), followed by the fusion peptide (FP), heptad repeat 1 (HR1), central helix (CH), connector domain (CD), heptad repeat 2 (HR2), transmembrane domain (TM), and cytoplasmic tail (CT) (Fig. 1). After binding ACE2 receptor, and following proteolysis at the furin and TMPRSS2 cleavage sites, the spike undergoes large conformational changes leading to cellular entry (6, 21–23). [Figure: SARS-CoV-2 spike (S) protein ectodomains for characterizing structures and antigenicity of S protein variants.(A) Domain architecture of the SARS-CoV-2 spike protomer. The S1 subunit contains a signal sequence (SS), the NTD (N-terminal domain, pale green), N2R (NTD-to-RBD linker, cyan), RBD (receptor binding domain, red), and SD1 and SD2 (subdomains 1 and 2, dark blue and orange). The S2 subunit contains the FP (fusion peptide, dark green), HR1 (heptad repeat 1, yellow), CH (central helix, teal), CD (connector domain, purple), and HR2 (heptad repeat 2, gray) regions. The transmembrane domain (TM) and cytoplasmic tail (CT) have been truncated and replaced by a foldon trimerization sequence (3), an HRV3C cleavage site (HRV3C), a His-tag (HIS), and a strep-tag (Strep). The D614G mutation (yellow star with green outline) is in SD2. The S1/S2 furin cleavage site (RRAR) has been mutated to GSAS (blue lightning). The substitutions in each variant are indicated by blue stars. *A few ectodomain constructs were prepared on the B.1.351 spike backbone; these differed in their NTD mutations (see table S1). Binding data for the other constructs, including the one representing the dominant circulating form (L18F, D80A, D215G, Δ242-244, K417N, E484K, N501Y, D614G, A701V), are shown in figs. S2 and S3. The construct shown here was used for determining the cryo-EM structure (Fig. 6). The “P.1-like” spike was prepared in the P.1 backbone but retained the K417N RBD substitution (instead of the K417T in the P.1 spike; see table S1). (B) Representation of the trimeric SARS-CoV-2 spike ectodomain in a prefusion conformation with one RBD up (PDB ID 7KDL). The S1 subunit on an RBD-down protomer is shown as a pale orange molecular surface; the S2 subunit is shown in pale green. The subdomains on an RBD-up protomer are colored according to (A) on a ribbon diagram. Each inset corresponds to the spike regions harboring mutations included in this study. (C and D) Binding of ACE2 (C) and of RBD-directed antibodies DH1041 and DH1047, NTD-directed antibodies DH1050.1 and DH1052, and S2-directed antibodies DH1058 and 2G12 (D) to spike variants measured by SPR. Data are representative of two independent experiments.] The autumn of 2020 was marked by the appearance of several fast-spreading SARS-CoV-2 variants with S protein variations accumulating in the background of the Asp614 → Gly (D614G) substitution (24). Some amino acid substitutions recur in variants that originated independently in different geographical locations, suggesting convergent evolution and selective advantages of these changes. Here, we determined the structures of S protein variants and measured the binding of these variants to ACE2 and Abs.. These include a variant that was implicated in SARS-CoV-2 transmission between humans and minks (25) and a few that originated and spread in human populations. Three RBD substitutions—Lys417 → Asn (K417N), Glu484 → Lys (E484K), and Asn501 → Tyr (N501Y)—occurred in the B.1.1.28 and the B.1.351 lineages that originated in Brazil and South Africa, respectively. The P.1 lineage, which branched off from B.1.1.28, incorporated a Lys417 → Thr (K417T) change and retained the E484K and N501Y substitutions. The N501Y substitution also occurred in the B.1.1.7 variant that originated in the UK (26–31). Our studies revealed different residue interaction networks in the variant spikes that converge on similar solutions for altering spike conformation and RBD up/down positioning. These findings elucidate the structural mechanisms underlying the effects of spike mutations on transmissibility and immune evasion. BINDING OF SARS-COV-2 S PROTEIN VARIANTS TO ACE2 RECEPTOR AND ANTIBODIES We used the previously described S-GSAS-D614G S ectodomain as a template here (Fig. 1 and table S1) (16) (referred to as “D614G spike” hereafter). This template includes SARS-CoV-2 S residues 1 to 1208, an Arg-Arg-Ala-Arg (RRAR) to Gly-Ser-Ala-Ser (GSAS) substitution that renders the furin cleavage site inactive, and a foldon trimerization motif at the spike C terminus, followed by a C-terminal TwinStrep tag. All purified S proteins showed similar migration profiles upon SDS–polyacrylamide gel electrophoresis (PAGE) and size exclusion chromatography (SEC), with high-quality spike preparations confirmed by negative-stain electron

Read the complete text